Astera Labs (NASDAQ:ALAB) Shares Up 9.2% – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was up 9.2% during trading on Monday . The stock traded as high as $353.79 and last traded at $346.33. Approximately 5,024,784 shares changed hands during trading, a decline of 9% from the average daily volume of 5,542,213 shares. The stock had previously closed at $317.06.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of analyst reports. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. TD Cowen raised their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Finally, UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Up 9.2%

The company has a market capitalization of $59.36 billion, a price-to-earnings ratio of 234.01, a P/E/G ratio of 4.20 and a beta of 3.95. The stock has a 50 day simple moving average of $212.95 and a 200 day simple moving average of $171.81.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity

In other news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the sale, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. The trade was a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,311,256 shares of company stock worth $477,341,446 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Atreides Management LP increased its position in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. boosted its stake in Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. Amundi grew its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC acquired a new stake in Astera Labs during the 3rd quarter valued at $209,599,000. Finally, BNP Paribas Financial Markets raised its stake in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.